Skip to main content
Bridging dolutegravir clinical viral response across doses and formulations using model-based exposure-response analysis in pediatrics.
Population-level viral suppression among pregnant and postpartum women in a universal test and treat trial.
Eliminating perinatal HIV in the United States: mission possible?
High levels of retention in care with streamlined care and universal test and treat in East Africa.
Increased adolescent HIV testing with a hybrid mobile strategy in Uganda and Kenya.
Antiretroviral exposure in utero and infancy: what do we know about African children in the age of option B+?
Hair concentrations of antiretrovirals predict viral suppression in HIV-infected pregnant and breastfeeding Ugandan women.
Efficacy and safety of lopinavir/ritonavir versus efavirenz-based antiretroviral therapy in HIV-infected pregnant Ugandan women.
Efficacy and safety of three regimens for the prevention of malaria in young HIV-exposed Ugandan children: a randomized controlled trial.
Predicting treatment failure in adults and children on antiretroviral therapy: a systematic review of the performance characteristics of the 2010 WHO immunologic and clinical criteria for virologic failure.